Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis

Introduction The increase in the number of patients with uncontrolled type 2 diabetes mellitus (T2DM) is in need of effective management interventions. However, research to date has been limited to the evaluation of the outcomes of community pharmacists alone. Therefore, the aim of the study protoco...

Full description

Bibliographic Details
Main Authors: Qingwei Zhao, Hongmei Wang, Dongsheng Hong, Yiqing Weng, Binghui Miao, Mengdie Zhang, Beijia Wang
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/10/e072960.full
_version_ 1827120373542420480
author Qingwei Zhao
Hongmei Wang
Dongsheng Hong
Yiqing Weng
Binghui Miao
Mengdie Zhang
Beijia Wang
author_facet Qingwei Zhao
Hongmei Wang
Dongsheng Hong
Yiqing Weng
Binghui Miao
Mengdie Zhang
Beijia Wang
author_sort Qingwei Zhao
collection DOAJ
description Introduction The increase in the number of patients with uncontrolled type 2 diabetes mellitus (T2DM) is in need of effective management interventions. However, research to date has been limited to the evaluation of the outcomes of community pharmacists alone. Therefore, the aim of the study protocol is to compare the effects of clinical pharmacist-led intervention strategies for the management of T2DM in the outpatient settings.Method and analysis The study will collect and analyse data applying standard Cochrane methodological procedures. A search for eligible studies and ongoing trials will be conducted using PubMed, Embase, Medline (via Ovid), EBSCO (via Ovid), Lippincott Williams & Wilkins (LWW) Journals (via Ovid), ProQuest Health and Medical Complete, and ClinicalTrials.gov (clinicaltrials.gov) from database inception to December 2023. Clinical and health outcomes will be measured using both glycaemic control related indicators (eg, glycated haemoglobin, fasting blood glucose, postprandial glucose) and general indicators (eg, adherence, disease management and health-related quality of life). The meta-analysis will conduct pairwise meta-analysis using random effects models and network meta-analysis (NMA) employing the Bayesian hierarchical model. The visualisation and statistical analysis will be carried out using RevMan, R Studio and ADDIS. Additionally, we will evaluate the certainty of the evidence by using Grading of Recommendations Assessment, Development and Evaluation system.Ethics and dissemination There will be no primary data collection from NMA participants, and there is no requirement for formal ethical review. Our aim is to present the results of this NMA in a peer-reviewed scientific journal, at conferences, and in the mainstream media.PROSPERO registration number CRD42022355368.
first_indexed 2024-03-11T13:25:51Z
format Article
id doaj.art-d5237f251bf64af481fbf8ab62bbdc08
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2025-03-20T13:36:13Z
publishDate 2023-10-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-d5237f251bf64af481fbf8ab62bbdc082024-09-12T08:15:10ZengBMJ Publishing GroupBMJ Open2044-60552023-10-01131010.1136/bmjopen-2023-072960Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysisQingwei Zhao0Hongmei Wang1Dongsheng Hong2Yiqing Weng3Binghui Miao4Mengdie Zhang5Beijia Wang62 Department of Clinical Pharmacy, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China2 Department of Clinical Pharmacy, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaIntroduction The increase in the number of patients with uncontrolled type 2 diabetes mellitus (T2DM) is in need of effective management interventions. However, research to date has been limited to the evaluation of the outcomes of community pharmacists alone. Therefore, the aim of the study protocol is to compare the effects of clinical pharmacist-led intervention strategies for the management of T2DM in the outpatient settings.Method and analysis The study will collect and analyse data applying standard Cochrane methodological procedures. A search for eligible studies and ongoing trials will be conducted using PubMed, Embase, Medline (via Ovid), EBSCO (via Ovid), Lippincott Williams & Wilkins (LWW) Journals (via Ovid), ProQuest Health and Medical Complete, and ClinicalTrials.gov (clinicaltrials.gov) from database inception to December 2023. Clinical and health outcomes will be measured using both glycaemic control related indicators (eg, glycated haemoglobin, fasting blood glucose, postprandial glucose) and general indicators (eg, adherence, disease management and health-related quality of life). The meta-analysis will conduct pairwise meta-analysis using random effects models and network meta-analysis (NMA) employing the Bayesian hierarchical model. The visualisation and statistical analysis will be carried out using RevMan, R Studio and ADDIS. Additionally, we will evaluate the certainty of the evidence by using Grading of Recommendations Assessment, Development and Evaluation system.Ethics and dissemination There will be no primary data collection from NMA participants, and there is no requirement for formal ethical review. Our aim is to present the results of this NMA in a peer-reviewed scientific journal, at conferences, and in the mainstream media.PROSPERO registration number CRD42022355368.https://bmjopen.bmj.com/content/13/10/e072960.full
spellingShingle Qingwei Zhao
Hongmei Wang
Dongsheng Hong
Yiqing Weng
Binghui Miao
Mengdie Zhang
Beijia Wang
Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
BMJ Open
title Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
title_full Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
title_fullStr Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
title_full_unstemmed Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
title_short Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
title_sort effects of pharmacist led interventions on glycaemic control adherence disease management and health related quality of life in patients with type 2 diabetes a protocol for a network meta analysis
url https://bmjopen.bmj.com/content/13/10/e072960.full
work_keys_str_mv AT qingweizhao effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis
AT hongmeiwang effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis
AT dongshenghong effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis
AT yiqingweng effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis
AT binghuimiao effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis
AT mengdiezhang effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis
AT beijiawang effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis